Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/3/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Wolfram E. Samlowski

Wrong Dr. Wolfram E. Samlowski?


Comprehensive Cancer Centers of Nevada (Affiliate of US Oncology)
Phone: (702) ***-****  HQ Phone
Comprehensive Cancer Centers of Nevada
7445 Peak Drive
Las Vegas , Nevada 89128
United States

Company Description: Comprehensive Cancer Centers of Nevada has provided adult and pediatric medical and radiation oncology services to Southern Nevada residents and visitors for more...   more

Employment History

Board Memberships and Affiliations


  • MD
  • medical degree
    Ohio State University
  • bachelor
    Ohio State University
  • M.D.
  • M.D. FACP
  • medical degree
    the Ohio State University
  • bachelor
    the Ohio State University
49 Total References
Web References
Wolfram Samlowski, MD, FACP - Comprehensive Cancer Centers of Nevada, 29 Nov 2012 [cached]
Wolfram Samlowski, MD, FACP
Wolfram Samlowski, MD, FACP
Home>Our Physicians> Wolfram Samlowski, MD, FACP
EDUCATION Dr. Samlowski earned his bachelor's and medical degree from Ohio State University in Columbus, Ohio. He completed his internal medicine residency at Wayne State University in Detroit, and his hematology oncology fellowship at the University of Utah in Salt Lake City.
AREAS OF SPECIAL INTEREST Melanoma and Renal Cancer
EXPERIENCE Prior to joining CCCN, Dr. Samlowski served as director of Translational Research, Multidisciplinary Melanoma program at the Huntsman Cancer Institute. He was professor of Oncology and adjunct professor of pathology and dermatology at the University of Utah, in Salt Lake City, where he worked from 1984 to 2007. In 2007, he joined the Nevada Cancer Institute as Chief, Section of Melanoma, Renal Cancer and Immunotherapy. He also was appointed professor of oncology. Dr. Samlowski has a teaching appointment as Clinical Professor at the University of Nevada, Reno.
PERSONAL Dr. Samlowski and his wife Suzanne recently celebrated their 30th anniversary.
Wolfram Samlowski, MD, FACP
BioMedicines || Scientific Advisors, 31 May 1999 [cached]
Wolfram Samlowski, M.D., Professor of Medicine, University of Utah.Dr. Samlowski has particular interest and experience in developing new regimens in patients with renal cell cancer or melanoma involving interleukin-2.
The institute has hired researcher Sheri ..., 25 June 2007 [cached]
The institute has hired researcher Sheri Holmen , of the Van Andel Research Institute in Michigan, and Dr. Wolfram Samlowski, an oncologist with the University of Utah.
Samlowski has been interested in melanoma for 20 years and will begin seeing patients in mid-July.
Skin cancer is most common in people in their 30s or 40s and is particularly deadly when it spreads to vital organs, Samlowski said.Progress has been slow in improving outcomes for advanced cases, he said, so the goal is to find new treatments to improve the survival rate.
"I'm driven by the patients and their families," Samlow-ski said."These are relatively young people at the prime of their life."
Samlowski said working with a private institution has several advantages over a university setting.At the University of Utah it might take six months to launch a promising drug study, whereas it will take about six weeks at Nevada Cancer Institute, he said.
"The emphasis of Nevada Cancer Institute is to develop new cancer treatments and bring them to the patients quickly," he said.
AACI Update / July 2008, 1 July 2008 [cached]
"This is a groundbreaking trial so the level of excitement is very high," said Dr. Wolfram Samlowski, NVCI chief, Section of Melanoma, Renal Cancer and Immunotherapy. The therapy is given intravenously. more...
News & Events - Nevada Cancer Institute, 13 July 2009 [cached]
Dr. Wolfram Samlowski Sponsored by Salt Lake City-based Myriad Pharmaceuticals Inc., the treatment, referred to as MPC-3100, is an investigational oral drug currently being studied in qualifying patients with untreatable or relapsed cancer. Wolfram Samlowski, M.D., NVCI head of the Section of Melanoma, Renal Cancer and Immunotherapy, is the principal investigator for the trial conducted at the Institute.
"This is another example of access to novel therapies that we can offer to patients in Nevada that are not yet widely available," Dr. Samlowski said.
Other People with the name "Samlowski":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.